PERPETUAL TUMOR BOARD

Serial Number 87624753
Registration 5927155
700

Registration Progress

Application Filed
Sep 27, 2017
Under Examination
Apr 24, 2018
Approved for Publication
Feb 27, 2018
Published for Opposition
Feb 27, 2018
Registered
Dec 3, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20191203) (Grace Period Filing)
Due: Jun 03, 2026 Grace Period - 115 days
Original deadline was Dec 03, 2025 (overdue)

Trademark Image

PERPETUAL TUMOR BOARD

Basic Information

Serial Number
87624753
Registration Number
5927155
Filing Date
September 27, 2017
Registration Date
December 3, 2019
Published for Opposition
February 27, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 3, 2019
Registration
Registered
Classes
009

Rights Holder

Avident Health LLC

16
Address
5209 Saint Albans Way
Baltimore, MD 21212

Ownership History

Avident Health LLC

Original Applicant
16
Baltimore, MD

Avident Health LLC

Owner at Publication
16
Baltimore, MD

Avident Health LLC

Original Registrant
16
Baltimore, MD

Legal Representation

Attorney
Frank S. Jones, Jr.

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20191203)
Due Date
December 03, 2025
Grace Period Ends
June 03, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Dec 3, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 3, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 31, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 30, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 30, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 29, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 24, 2019 IUAF S USE AMENDMENT FILED Loading...
Oct 29, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 24, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 29, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 24, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 24, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 5, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 3, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 3, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 3, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 25, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 23, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 23, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 23, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 24, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 27, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 27, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 7, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 19, 2018 ALIE A ASSIGNED TO LIE Loading...
Jan 9, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 9, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 9, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 9, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 9, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 4, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 3, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 30, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 009
Downloadable mobile applications for use by cancer care providers, teams and patients with capabilities to continuously communicate via real-time chat, text messaging, document sharing and/or videoconferencing
First Use Anywhere: Sep 30, 2019
First Use in Commerce: Sep 30, 2019

Classification

International Classes
009

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TUMOR BOARD"